Maryland Subject | Pharmacy Benefits Managers | Introduced

Filter View [Reset All]
Syndicate content
StanceStateBillStatusSummary/TitleLast Actionsort icon
MDHB1270Intro
25%
Requiring that the calculation of an enrollee's contribution to a cost sharing requirement for a prescription drug be based on the list price of the drug reduced by at least 85% of the total amount of rebates received or expected to be received by th...
[Detail][Text][Discuss]
2024-03-16
Withdrawn by Sponsor
MDSB497Intro
25%
Requiring the Maryland Medical Assistance Program and certain insurers, nonprofit health service plans, and health maintenance organizations to cover nonprescription naloxone hydrochloride and any other drug or product that is approved by the federal...
[Detail][Text][Discuss]
2024-03-04
Withdrawn by Sponsor
MDHB736Intro
25%
Requiring the Maryland Medical Assistance Program and certain insurers, nonprofit health service plans, and health maintenance organizations to cover nonprescription naloxone hydrochloride and any other drug or product that is approved by the federal...
[Detail][Text][Discuss]
2024-02-26
Withdrawn by Sponsor
MDHB880Intro
25%
Altering the reimbursement levels for drug products that the Maryland Medical Assistance Program is required to establish and that pharmacy benefits managers that contract with a pharmacy on behalf of a managed care organization are required to reimb...
[Detail][Text][Discuss]
2024-02-09
To House Health and Government Operations Committee
MDHB1368Intro
25%
Prohibiting certain health insurance entities from taking certain actions with respect to the dispensing of clinician-administered drugs and related services; and authorizing certain health insurance entities to allow the use of a certain pharmacy or...
[Detail][Text][Discuss]
2024-02-09
To House Health and Government Operations Committee
MDSB1021Intro
25%
Altering the reimbursement levels for drug products that the Maryland Medical Assistance Program is required to establish and that pharmacy benefits managers that contract with a pharmacy on behalf of a managed care organization are required to reimb...
[Detail][Text][Discuss]
2024-02-06
To Senate Finance Committee
MDSB1019Intro
25%
Requiring that the calculation of an enrollee's contribution to a cost sharing requirement for a prescription drug be based on the list price of the drug reduced by at least 85% of the total amount of rebates received or expected to be received by th...
[Detail][Text][Discuss]
2024-02-06
To Senate Finance Committee
MDSB626Intro
25%
Altering the definition of "purchaser" for the purpose of certain provisions of State insurance law governing pharmacy benefits managers to exclude certain nonprofit health maintenance organizations; and repealing certain provisions that restrict app...
[Detail][Text][Discuss]
2024-02-02
To Senate Finance Committee
MDSB754Intro
25%
Prohibiting certain health insurance entities from taking certain actions with respect to the dispensing of clinician-administered drugs and related services; and authorizing certain health insurance entities to allow the use of a certain pharmacy or...
[Detail][Text][Discuss]
2024-02-02
To Senate Finance Committee
MDSB526Intro
25%
Prohibiting certain pharmacy benefits managers from requiring a beneficiary to use a specific pharmacy or entity for a specialty drug if the drug is dispensed by a physician, used in the treatment of a certain condition, and meets other requirements;...
[Detail][Text][Discuss]
2024-01-24
To Senate Finance Committee
Syndicate content
feedback